Clinical Trial: Study to Evaluate MEDI-534 in Healthy Adults

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Dose-Escalating Study to Evaluate MEDI-534 in Healthy Adults

Brief Summary: The primary objective of this study is to describe the safety and tolerability of a single dose of MEDI-534 when administered to healthy adult volunteers.

Detailed Summary:
Sponsor: MedImmune LLC

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: MedImmune LLC

Dates:
Date Received: May 26, 2005
Date Started: April 2005
Date Completion: December 2005
Last Updated: July 2, 2007
Last Verified: July 2007